Callicarpa arborea
Callicarpa arborea
Callicarpa arborea, a plant native to Asia, particularly India and China, has not been traditionally used for medicinal purposes. However, recent scientific research indicates potential therapeutic benefits. Compounds extracted from Callicarpa arborea have shown promise as inhibitors of the NLRP3 inflammasome, which could be beneficial in reducing inflammation. Additionally, these compounds exhibit significant cytotoxic effects against breast and colorectal cancer cells, suggesting possible anti-cancer properties. The methanolic extract of its leaves also demonstrated notable analgesic and anti-inflammatory activity in mice studies. To date, no major safety concerns or drug interactions have been reported for this plant, but further research is needed to confirm these findings comprehensively.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Compound 1 from Callicarpa arborea showed potential as an NLRP3 inflammasome inhibitor by reducing GSDMD-NT production, inhibiting caspase-1 activation, and suppressing IL-1β secretion.
- Compounds 2 and 3 from Callicarpa arborea showed significant cytotoxic effects against breast and colorectal cancer cells, inducing apoptosis.
- Compound 3 from Callicarpa arborea shows strong potential as an NLRP3 inflammasome activation inhibitor with an IC50 value of 3.153 μM.
- The methanolic extract of Callicarpa arborea Roxb. leaves showed significant analgesic and anti-inflammatory activity in mice.
Frequently asked questions
What is Callicarpa arborea?
Callicarpa arborea (Callicarpa arborea) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Callicarpa arborea?
4 sourced findings are recorded for Callicarpa arborea; the strongest carries evidence grade D. For example: Compound 1 from Callicarpa arborea showed potential as an NLRP3 inflammasome inhibitor by reducing GSDMD-NT production, inhibiting caspase-1 activation, and suppressing IL-1β secretion.
How strong is the evidence for Callicarpa arborea?
The strongest finding for Callicarpa arborea carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Callicarpa arborea safe? What are the side effects?
No major safety issues are recorded for Callicarpa arborea in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Callicarpa arborea interact with medications?
No drug interactions are recorded for Callicarpa arborea in our sources. This does not rule them out — check with a pharmacist.
Is Callicarpa arborea a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Callicarpnoids A-C, structurally intriguing ent-Clerodane diterpenoid dimers with cytotoxicity against MCF-7 and HCT-116 cell lines from Callicarpa arborea Roxb. literature abstract metadata
- T2 Analgesic, anti-inflammatory activity and metabolite profiling of the methanolic extract of Callicarpa arborea Roxb. leaves. literature abstract metadata
- T2 Two New Prostaglandin-Like Compounds from Callicarpa arborea Roxb and Their NLRP3 Inflammasome Activation Inhibitory Activity. literature abstract metadata
- T2 Three New Clerodane Diterpenoids and Their NLRP3 Inflammasome Activation Inhibitory Activity from Callicarpa arborea Roxb. literature abstract metadata